findmyKOL

Colleen Halfpenny, MD

Basic profile

Sidney Kimmel Cancer Center

ORCIDNone on fileNPI
RegionHuntingdon Valley, PA · NortheastSpecialtyOphthalmologyFocusOphthalmology
Active KOLfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2023Online presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

Colleen Halfpenny is an Ophthalmology physician affiliated with Sidney Kimmel Cancer Center. OpenAlex indexes 12 publications with 309 citations (h-index 8).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
12publications

Distinct works indexed by OpenAlex.

309citations

Total citations across indexed works.

8h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
11companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

2755 Philmont Ave Ste 140
Huntingdon Valley, PA 190065321

Telephone

215-938-7878

Registry record last updated 18 Mar 2019.

View the NPPES registry record

Industry payments

11 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

View the CMS Open Payments record ↗

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Sensory organs

    56.8%
    Prostaglandin Analog25.9%
    Latanoprost82%Lumigan12%Travoprost6%
    Part D<11 patients
    Corticosteroid7.9%
    Prednisolone Acetate100%
    Part D70 patients

    + 6 more classes in this area

  • Anti-infectives

    22.2%
    Macrolide13.8%
    Erythromycin100%
    Part D105 patients
    Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor4.3%
    Valacyclovir100%
    Part D19 patients

    + 1 more class in this area

  • Cancer & immunology

    15%
    Calcineurin inhibitor15%
    Restasis65%Cyclosporine35%
    Part D55 patients
Where care is delivered (Part B)5.2% facility · 94.8% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”